Rather than measuring all viral material present in a sample, the assay focuses on cells that retain the ability to release infectious virus or transmit infection. Infected cells are diluted and exposed to susceptible cells, so the resulting count reflects functional infectivity associated with cells. This distinction is useful when viral material is present but does not represent infectious activity.
A permissive cell monolayer provides the susceptible cellular environment needed for infection to spread from an infectious cell. If the plated cells are not permissive, transmission may not generate a visible focus or plaque, reducing what the assay can reveal. Thus, the monolayer links cell-associated infectivity to a countable localized signal.
Localized foci or plaques convert transmission events into countable readouts. A focus or plaque forms when an infectious cell initiates infection in neighboring susceptible cells; immunostaining can identify infected areas, while cytopathic changes provide an alternative visible indication. The selected readout determines how infectious centers are recognized and counted after plating.
The workflow begins with infected cells, followed by dilution and plating onto a permissive cell monolayer. After infectious cells initiate localized transmission, investigators identify the resulting foci or plaques through immunostaining or visible cytopathic changes. Counting these localized signals provides an estimate of infectious centers and supports analysis of cell-associated infectivity.
Researchers can apply the assay when they need to evaluate viral dissemination or transmission between cells rather than simply detect viral material. It can also compare how susceptible host cells are to infection or how effectively infection remains associated with cells. These uses make the method relevant to studies of pathogen spread and cellular infection behavior.
In immunology and infection research, changes in infectious-center counts can help assess immune-mediated control of infection. The assay can also evaluate neutralizing antibody activity by examining how antibody activity affects the ability of infected cells to generate infectious transmission. Results connect an immune intervention with a functional outcome based on detectable infectious centers.